Bayer Aspirin Expands U.S. Presence with Aspirina Launch
PorAinvest
viernes, 15 de agosto de 2025, 10:09 pm ET1 min de lectura
WBA--
Aspirina contains 500 mg of aspirin, providing fast and effective relief for headaches, muscle pain, toothaches, menstrual pain, and minor arthritis pain. The product is coated for easy swallowing and is free of caffeine. Its availability in the US market is a strategic move to cater to the growing Hispanic population, which currently represents 19% of the US population and is projected to reach 28% by 2060 [1].
Mohamed Atef, Global Brand Lead for Aspirin at Bayer, emphasized the importance of connecting with the Hispanic community. He stated, "Many Hispanic communities still face inadequate access to healthcare and consumer goods. By adding Aspirina to the US portfolio, which has a strong equity in LATAM, we are placing the consumer at the center of our strategy. Data shows that 70% of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment" [1].
Aspirina's introduction to the US market is expected to tap into the deep-rooted trust and nostalgia for the brand among Hispanic consumers. With a 99% awareness rate in Mexico and 67% of consumers using it regularly, Aspirina is poised to become a familiar and reliable pain relief option for many families [1].
Bayer, which invented modern aspirin 125 years ago, continues to be one of the most trusted pain brands on the market. The company's mission is to "Health for all, Hunger for none," and its products and services are designed to help people and the planet thrive [2].
References:
[1] https://www.nasdaq.com/press-release/bayerr-aspirin-introduces-aspirina-us-pain-market-2025-08-15
[2] https://www.morningstar.com/news/business-wire/20250815242095/bayer-aspirin-introduces-aspirina-to-the-us-pain-market
WMT--
Bayer has introduced Aspirina to the US pain market, now available for purchase at select Walmart and Walgreens stores. Aspirina is Bayer's aspirin brand, expanding its presence in the US market.
Bayer, a global leader in healthcare and nutrition, has introduced Aspirina to the US pain market. The product, available for purchase at select Walmart and Walgreens stores, is Bayer's aspirin brand, expanding its presence in the US market. Aspirina is a trusted pain reliever and fever reducer that has been a staple in the Mexican and Latin American communities for generations.Aspirina contains 500 mg of aspirin, providing fast and effective relief for headaches, muscle pain, toothaches, menstrual pain, and minor arthritis pain. The product is coated for easy swallowing and is free of caffeine. Its availability in the US market is a strategic move to cater to the growing Hispanic population, which currently represents 19% of the US population and is projected to reach 28% by 2060 [1].
Mohamed Atef, Global Brand Lead for Aspirin at Bayer, emphasized the importance of connecting with the Hispanic community. He stated, "Many Hispanic communities still face inadequate access to healthcare and consumer goods. By adding Aspirina to the US portfolio, which has a strong equity in LATAM, we are placing the consumer at the center of our strategy. Data shows that 70% of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment" [1].
Aspirina's introduction to the US market is expected to tap into the deep-rooted trust and nostalgia for the brand among Hispanic consumers. With a 99% awareness rate in Mexico and 67% of consumers using it regularly, Aspirina is poised to become a familiar and reliable pain relief option for many families [1].
Bayer, which invented modern aspirin 125 years ago, continues to be one of the most trusted pain brands on the market. The company's mission is to "Health for all, Hunger for none," and its products and services are designed to help people and the planet thrive [2].
References:
[1] https://www.nasdaq.com/press-release/bayerr-aspirin-introduces-aspirina-us-pain-market-2025-08-15
[2] https://www.morningstar.com/news/business-wire/20250815242095/bayer-aspirin-introduces-aspirina-to-the-us-pain-market

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios